CClinicalTrials.gg
CompletedNCT07753044Updated Aug 7, 2026

Photoactivated Disinfection Versus Laser Disinfection of Infected Sockets on the Success of Immediate Implant Placement

An interventional study of Photoactivated disinfection and Er,Cr:YSGG laser disinfection in Infected Extraction Sockets, sponsored by Alexandria University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by Alexandria University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

Background: Dental implantology offers reliable tooth replacement options, but infections in extraction sockets can compromise osseointegration. Conventional disinfection methods, such as chlorhexidine, often fail to completely eliminate pathogenic microorganisms and may impair tissue healing. Photoactivated disinfection (PAD) and laser disinfection have emerged as promising alternatives. PAD employs a light-activated photosensitizer to generate reactive oxygen species (ROS), effectively disrupting bacterial membranes while preserving host cell viability. In parallel, laser disinfection utilizes focused light energy to eliminate bacterial biofilms and contaminated tissue with minimal thermal damage. In this study, we specifically utilize the Er,Cr:YSGG laser, which operates at a water-absorbing wavelength to induce micro-explosions that mechanically disrupt biofilms and promote a cleaner socket environment for improved osseointegration. Aim of the study: To compare the effectiveness of photoactivated disinfection (PAD), Er,Cr:YSGG laser disinfection, and conventional disinfection with chlorhexidine in decontaminating infected extraction sockets prior to immediate implant placement, promoting bone healing, and improving the osseointegration and stability of immediate implants placed in infected extraction sockets.

02

Conditions studied

  • Infected Extraction Sockets
03

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients having posterior tooth/teeth indicated for extraction
  • Patients must exhibit radiographic evidence of infection, defined as chronic periapical pathology (radiolucency)
  • The extraction site should have intact surrounding alveolar bone
  • There must be at least 2 mm of sound bone beyond the root apex
  • Patients must be in overall good health and free from uncontrolled systemic conditions

Exclusion criteria

Exclusion Criteria:

  • History of radiation therapy in the head and neck region
  • Pregnant or lactating women
  • Patients on long-term antibiotic therapy, as it could influence the outcomes
  • Heavy Smoking: More than 10-15 cigarettes per day.
  • Significant bruxism or parafunctional habits affecting implant stability.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    PAD

    Other: Photoactivated disinfection

  • Experimental
    Er,Cr:YSGG laser Group

    Other: Er,Cr:YSGG laser disinfection

  • Active comparator
    Conventional group

    Other: Chlorohexidine disinfection

Interventions

  • OtherPhotoactivated disinfection

    Standard treatment + Toluidine blue + Light activation + Immediate implant placement

  • OtherEr,Cr:YSGG laser disinfection

    Standard treatment + Er,Cr:YSGG laser application + Immediate Implant placement

  • OtherChlorohexidine disinfection

    Standard treatment + Chlorohexidine Irrigation + Immediate Implant placement

05

What researchers measure

Primary outcomes

  1. implant stability

    Resonance Frequency Analysis (RFA) using Osstell ISQ: Implant Stability Quotient (ISQ) values will be recorded at 6 months after implant placement. Values from 1 to 100, the higher the ISQ, the higher the stability of the implant.

    Time frame: 6 months

  2. change in bone density

    Bone density assessment using radiographs immediately post-operative and at 6 months.

    Time frame: baseline and 6 months

  3. change in marginal bone loss

    Marginal Bone Loss (MBL) assessment using radiographs immediately postoperative and at 6 months.

    Time frame: baseline and 6 months

Secondary outcomes

  1. change in pain scores

    Post-operative pain will be assessed through a 10-point visual analogue scale (VAS). (0-1 = No pain, 2-4 = mild pain, 5-7 = moderate pain, 8-10 = severe pain).

    Time frame: up to 7 days

  2. change in post-operative edema

    Post-operative edema will be assessed as follows None (no swelling), Mild (intra oral swelling confined to surgical field), Moderate (extra oral swelling in the surgical zone), Severe (extra oral swelling spreading beyond the surgical zone)

    Time frame: up to 7 days

06

Study locations

1 site
  • Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt
    Alexandria, Azarita 00203, Egypt
07

Registry details

Key details

Study ID
NCT07753044
Lead sponsor
Alexandria University
Responsible party
Sponsor
First posted
Aug 7, 2026
Start date
Jun 10, 2025
Primary completion
Feb 3, 2026
Completion
Feb 3, 2026
Last update
Aug 7, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion